Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Sep 15;10(2):367–374. doi: 10.1111/jdi.12889

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMC Copyright notice

(a) Comparison of changes in glycated hemoglobin (HbA1c) before and after treatment in each group. (b) Comparison of changes in the glycated albumin (GA) to HbA1c (GA/HbA1c) ratio before and after treatment in each group. Values are means, and P‐values were generated using paired or unpaired Student's t‐tests, with **P < 0.01 representing statistical significance. Repaglinide, the group that switched from sulfonylurea to repaglinide from the start of the trial period; SU, the group that continued sulfonylurea during the trial period.